Home/VALANX Biotech/Klaus Orlinger
KO

Klaus Orlinger

Chief Scientific Officer

VALANX Biotech

Therapeutic Areas

VALANX Biotech Pipeline

DrugIndicationPhase
GoldenSite™-enabled next generation protein-drug-conjugatesNot Disclosed (Oncology focus)Preclinical